Apc deficiency predisposes to renal carcinoma in the mouse

Owen J Sansom1, David F R Griffiths, Karen R Reed

  • 1Cardiff School of Biosciences, Cardiff University, Wales CF10 3US, UK.

Oncogene
|August 24, 2005
PubMed

Insights

The Adenomatous Polyposis Coli (Apc) gene is crucial for suppressing kidney cancer. Inactivating Apc in mice led to rapid renal carcinoma development, highlighting its tumor-suppressive role.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Wnt signaling pathway deregulation is linked to human renal cancer.
  • The Adenomatous Polyposis Coli (Apc) gene plays a role in Wnt pathway regulation.

Purpose of the Study:

  • To investigate the direct association between Apc gene inactivation and renal cancer development.
  • To establish a murine model for studying Apc's role in renal tumorigenesis.

Main Methods:

  • Utilized a Cre-LoxP strategy to conditionally inactivate the Apc gene in murine renal epithelium.
  • Generated mice with conditional Apc alleles crossed with Cre recombinase transgenic mice (Cyp1A promoter).

Main Results:

  • Apc inactivation resulted in nuclear beta-catenin accumulation and rapid development of dysplastic foci.
  • Renal carcinoma onset observed as early as 4 months in Apc-deficient mice.
  • p53 deficiency accelerated renal carcinoma onset to 2 months.

Conclusions:

  • Apc is a critical suppressor of renal carcinoma in mice.
  • This model demonstrates a particularly rapid onset of kidney neoplasia, underscoring Apc's importance.